Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jan;73(1):124–127. doi: 10.1038/bjc.1996.23

Human papillomavirus DNA as a factor determining the survival of bladder cancer patients.

A Lopez-Beltran 1, A L Escudero 1, L Vicioso 1, E Muñoz 1, J C Carrasco 1
PMCID: PMC2074275  PMID: 8554974

Abstract

The natural history of transitional cell carcinoma (TCC) of the urinary bladder is somewhat variable, with a significant number of tumour recurrences that occasionally evolve towards an infiltrating disease. The aim of this study was to investigate the presence of human papillomavirus (HPV) DNA in 76 TCC specimens, and then correlate such findings with the overall patient survival. However, other classical prognostic clinical and pathological variables such as pathological grade and stage, koilocytosis, age and sex were also tested. HPV DNA was investigated by means of the highly sensitive polymerase chain reaction (PCR). DNA primers specific for HPV types 6, 11, 16 and 18 were used. Our results showed that 7 (9.21%) out of 76 such cases were reactive for HPV 16 DNA; one of them also reacted with HPV 6 DNA. The statistical analysis was done by the Kaplan-Meier method, Wilcoxon's generalised test for studying the differences in survival curves and Cox's regression analysis for independent prognostic factors. A significant P-value was found for pathological grade (P < 0.0001) and stage (P < 0.0001), HPV 16 DNA (P = 0.0418) and koliocytosis (P = 0.0140). Thus, pathological grade was the only independent factor in the bladder cancer survival. These observations may prove useful in prognostic stratification of patients with TCC of the bladder.

Full text

PDF
124

Images in this article

125Figure 1
on p.125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anwar K., Naiki H., Nakakuki K., Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer. 1992 Oct 1;70(7):1967–1973. doi: 10.1002/1097-0142(19921001)70:7<1967::aid-cncr2820700726>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  2. Bryant P., Davies P., Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol. 1991 Jul;68(1):49–52. doi: 10.1111/j.1464-410x.1991.tb15256.x. [DOI] [PubMed] [Google Scholar]
  3. Chang F., Lipponen P., Tervahauta A., Syrjänen S., Syrjänen K. Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction. J Urol. 1994 Nov;152(5 Pt 1):1429–1433. doi: 10.1016/s0022-5347(17)32437-0. [DOI] [PubMed] [Google Scholar]
  4. Chetsanga C., Malmström P. U., Gyllensten U., Moreno-Lopez J., Dinter Z., Pettersson U. Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer. 1992 Mar 1;69(5):1208–1211. doi: 10.1002/cncr.2820690523. [DOI] [PubMed] [Google Scholar]
  5. Del Mistro A., Koss L. G., Braunstein J., Bennett B., Saccomano G., Simons K. M. Condylomata acuminata of the urinary bladder. Natural history, viral typing, and DNA content. Am J Surg Pathol. 1988 Mar;12(3):205–215. doi: 10.1097/00000478-198803000-00006. [DOI] [PubMed] [Google Scholar]
  6. Donaldson Y. K., Arends M. J., Duvall E., Bird C. C. PCR analysis of the upstream regulatory region of human papillomavirus genomes in cervical intraepithelial neoplasia and cervical carcinoma. J Clin Pathol. 1993 Nov;46(11):1021–1023. doi: 10.1136/jcp.46.11.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Furihata M., Inoue K., Ohtsuki Y., Hashimoto H., Terao N., Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 1993 Oct 15;53(20):4823–4827. [PubMed] [Google Scholar]
  8. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  9. Hartveit F., Maehle B. O., Thunold S. Koilocytosis in neoplasia of the urinary bladder. Br J Urol. 1992 Jan;69(1):46–48. doi: 10.1111/j.1464-410x.1992.tb15457.x. [DOI] [PubMed] [Google Scholar]
  10. Howley P. M. Role of the human papillomaviruses in human cancer. Cancer Res. 1991 Sep 15;51(18 Suppl):5019s–5022s. [PubMed] [Google Scholar]
  11. Karlsen F., Kalantari M., Chitemerere M., Johansson B., Hagmar B. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest. 1994 Oct;71(4):604–611. [PubMed] [Google Scholar]
  12. Kitamura T., Yogo Y., Ueki T., Murakami S., Aso Y. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res. 1988 Dec 15;48(24 Pt 1):7207–7211. [PubMed] [Google Scholar]
  13. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  14. Lopez-Beltran A., Croghan G. A., Croghan I., Huben R. P., Mettlin C., Gaeta J. F. Prognostic factors in survival of bladder cancer. Cancer. 1992 Aug 15;70(4):799–807. doi: 10.1002/1097-0142(19920815)70:4<799::aid-cncr2820700414>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  15. Lopez-Beltran A., Croghan G. A., Croghan I., Matilla A., Gaeta J. F. Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study. Am J Clin Pathol. 1994 Jul;102(1):109–114. doi: 10.1093/ajcp/102.1.109. [DOI] [PubMed] [Google Scholar]
  16. Lopez-Beltran A., Muñoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology. 1995 Jun;26(6):565–569. doi: 10.1111/j.1365-2559.1995.tb00276.x. [DOI] [PubMed] [Google Scholar]
  17. Querci della Rovere G., Oliver R. T., McCance D. J., Castro J. E. Development of bladder tumour containing HPV type 11 DNA after renal transplantation. Br J Urol. 1988 Jul;62(1):36–38. doi: 10.1111/j.1464-410x.1988.tb04261.x. [DOI] [PubMed] [Google Scholar]
  18. Saltzstein D. R., Orihuela E., Kocurek J. N., Payne D. A., Chan T. S., Tyring S. K. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res. 1993 Mar-Apr;13(2):423–425. [PubMed] [Google Scholar]
  19. Stoler M. H., Rhodes C. R., Whitbeck A., Wolinsky S. M., Chow L. T., Broker T. R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol. 1992 Feb;23(2):117–128. doi: 10.1016/0046-8177(92)90232-r. [DOI] [PubMed] [Google Scholar]
  20. Wilczynski S. P., Oft M., Cook N., Liao S. Y., Iftner T. Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Hum Pathol. 1993 Jan;24(1):96–102. doi: 10.1016/0046-8177(93)90068-r. [DOI] [PubMed] [Google Scholar]
  21. Yu S. T., Wu M. M., Li L. M. Prevalence of human papillomaviruses 16 and 18 in transitional cell carcinoma of bladder. Chin Med J (Engl) 1993 Jul;106(7):494–496. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES